Synaptogenix Inc (SNPX)

[resident1]

1500 cancer patients were on high doses, some for over a year. I don't get the safety concerns people have here. Sure maybe it doesn't end up working, but I think the safety is generally pretty well tested by now. It would be even easier to see a 'brain' related safety issue in cancer patients, because if you've ever been around a person with AD, it's brain degradation... you never know if it's just one more thing that has gone, or maybe the drug. I'm much more satisfied with safety data from people with cancer, where they have their faculties, so if you see something 'brain' related (sorry for just dumbing this down) you might think, hey this is because of the drug.

I think the short trial is to see quickly if it has an effect as theorized and confirm the results of the CU patients, and be able to get to an actual P3 and partner in the quickest amount of time.

Also, I don't know how many of you have ever had a close family member with AD, but I can tell you with 100% certainty that we would have paid $1500 for just one day of greater clarity, to have the person back for just one moment. If it "only" works for three months and shows any improvement would truly have been a miracle to us. The bar is really low here.